2017 annual financial data
Protagonist Therapeutics 2017 Operating cash flow margin
Direct answer
Operating cash flow margin was 19.3%.
Operating income was -37,897,000 USD and net income was -36,957,000 USD.
Operating cash flow was 3,872,000 USD.
Get free Protagonist Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 20,063,000 USD
- Operating income
- -37,897,000 USD
- Net income
- -36,957,000 USD
- Operating cash flow
- 3,872,000 USD